Stopped-flow kinetics indicate that human and chicken heart-type4 lactate dehydrogenases (LDH) become inhibited as DPNH is oxidized in the presence of high concentrations of pyruvate. This inhibition is much less marked with the human and chicken muscle-type4 enzymes. The initial rates and the difference in inhibition between the two types of enzyme have made it possible to determine the amount of, as well as the ratio between, the two types of LDH that are present in a given sample by a single kinetic assay. The stopped-flow kinetic method has been used to analyze amounts of LDH isoenzyme in different tissues, as well as in serum.
Significant kinetic differences exist between chicken heart (H) and chicken muscle (M) lactate dehydrogenase (LDH) (1) (2) (3) . At high pyruvate concentrations, or after previous incubation with DPN+, the heart enzyme is inhibited to a greater extent than the muscle enzyme (3) . Similar differences have been found between the enzymes from human heart and human liver (4) .
The kinetic behavior of the various isoenzymes of LDH is governed by their subunit composition. Hence, the H2M2 isoenzyme will exhibit kinetics that are almost identical with those of a mixture of equal amounts of H4 and M4 LDH (5) .
Concentrations of LDH and isoenzyme patterns are important in clinical diagnosis. Vessell and Bearn noted that the isoenzyme pattern of serum changes after myocardial infarction (6) . Changes in the isoenzyme pattern are observed as early as [6] [7] [8] [9] [10] [11] [12] hr after the initial attack of pain and have been shown, in dogs, to be a more sensitive indicator of myocardial necrosis than total serum activity (7) . Changes in LDH isoenzyme patterns are a constant feature in diseases where liver-cell damage occurs (8) . Malignancies, hemolytic anemias, and muscular dystrophy will also alter LDH concentrations and isoenzyme patterns of serum (9) . The changes are usually evaluated by electrophoretic methods, which are considerably time-consuming. We are reporting a method involving a single assay taking less than a minute that determines the total amount of LDH, as well as the relative concentration of H and M subunits. This method is based on the difference in inhibition of the two different types of LDH at high concentrations of pyruvate.
MATERIALS AND METHODS
Materials. Pyruvate was purchased from Calbiochem. DPN+ and DPNH were purchased from P-L Biochemicals.
DE-1 1 is a product of Reeves-Angel. Chicken tissues were obtained from commercial sources. Human tissues were provided from autopsy material of the University Hospital of San Diego County. Normal human serum was purchased from the San Diego Blood Bank. All other reagents were purchased from commercial sources.
Enzyme Preparations. Chicken H4 and M4 and human H4 enzymes were prepared by the method of Pesce et al. (10, 11) . Human hybrid enzymes H3M1, H2M2, and H1M3 were separated from human heart extracts by ion-exchange chromatography with DE-11 cellulose (12 The data are presented as the ratio of the activity obtained in 10 mM pyruvate to that obtained with 0.33 mM pyruvate.
RESULTS

Inhibition by high concentrations of pyruvate
When extracts of human heart tissue and liver tissue were assayed in the Stopped-Flow Spectrophotometer with various amounts of pyruvate, a significant inhibition of the heart enzyme occurred at high pyruvate concentrations, whereas the inhibition was much less pronounced with the enzyme from liver ( Table 1 ). The data are presented as the ratio of activity obtained in the presence of 10 mM pyruvate (pyrH), with respect to that obtained with 0.33 mM pyruvate (pyrL). The data indicate that at pH 7.5, very little inhibition by high concentrations of pyruvate is observed with the muscle isoenzyme, whereas the heart enzyme shows almost 50% inhibition.
These results are similar to those obtained with the lactate dehydrogenases from chicken (3) , and confirm the results that were obtained by other workers with human LDH (4) .
Elevation of the temperature from 200 to 370 results in an overall decrease of the inhibition by pyruvate, as indicated by an increase in pyrT/pyrL ratios; however, the relative inhibition of the heart enzyme as compared to that of the liver enzyme appears not to be significantly affected by the change in temperature (see Table 1 ).
Addition of oxidized coenzymes
The inhibition of chicken LDH by high concentrations of pyruvate appears to be the result of the formation of an abortive ternary complex of LDH, DPN+, and pyruvate (3, 13) . The formation of such a complex occurs much more readily with the H-type LDH than with the M-type enzyme. Consequently, the addition of oxidized coenzymes to the reaction mixture generally results in an increased inhibition, and the increase in inhibition is more pronounced when the enzyme is incubated for a few minutes with DPN+ and pyruvate before the initiation of the reaction by the addition of DPNH (3). Similar observations have been made with the human enzymes. Incubation of the human heart extract with 0.1 mM DPN+ and 0.01 M pyruvate for 10 min resulted in an inhibition of more than 80% of the LDH activity, whereas the inhibition in the absence of DPN+ was about 45%. This phenomenon is even more pronounced when the DPN+ is replaced by its acetylpyridine analog [(AcPy)DPN+]. Table 2 summarizes the percent inhibition that is obtained with the human heart and liver extracts with various concentrations of (AcPy)DPN+. The data indicate that a significant inhibition is observed when as little as 1.4 X 10-7 M (AcPy)DPN+ is present in the reaction mixture. Inhibition of enzymatic activity was also evident when purified human enzymes were used. Equal activities of the H4 and M4 enzyme were both inhibited upon previous incubation with oxidized coenzyme, but to different extents.
After 5 min of incubation in 1 mM pyruvate and 28 AM DPN+, the M4 enzyme retained 75% of its initial activity, while the H4 enzyme exhibited only 23% of its initial activity. These results dramatize the effects of low concentrations of oxidized coenzyme on the two types of human LDH. When chicken 114 LDH is assayed in the presence of high pyruvate concentrations, no substrate inhibition is observed during the initial part of the reaction; the phenomenon becomes observable only after a certain amount of DPN+ has been formed (14) . Thus, in the presence of high pyruvate concentrations, the activity of the H4 enzyme is maximal during the first second or less, the time being dependent on the amount of enzyme present in the assay. During the progress of the reaction, the activity of the enzyme decreases as a result of the formation of the abortive complex until a steady state is obtained and the reaction proceeds more or less linearly with time ( Fig. 1 and Table 3 ). The chicken M4 enzyme remains uninhibited, whereas the chicken H4 enzyme is inhibited 66%. Similar observations were made with purified human H4 and M4 LDH. The human H4, like the chicken H4, has a steady-state velocity about one-third of the initial velocity. However, human M4 LDH, unlike chicken M4 LDH, also shows significant inhibition, retaining in the steady state only slightly over half of its initial activity. The inhibitory effects on the human enzyme are also demonstrated in Fig. 2 , in which the three stages of the reaction-the initial stage, the stage of complex formation, and the steady state-are clearly observable. The curves for time against absorbance of equal activities of the two enzymes measured at 0.2 mM pyruvate are also shown. Both are essentially identical and linear, showing no significant inhibition.
The degree of inhibition of the enzymes is a function of the concentration of pyruvate that is present in the reaction mixture, as shown in Table 1 . When the pyruvate concentration is increased, first the 14 enzyme is inhibited, and at higher concentrations, the M4 enzyme is inhibited as well. We found that the greatest difference in the steady-state rates of equal activities of the two enzymes, when done in the The uppermost line shows time against Am0 for both 114 and M4 enzymes at 0.2 mM pyruvate. The curve is actually composed of the two curves superimposed. At high pyruvate concentration (20 mM), the steady-state rate of the M4 enzyme is somewhat inhibited, whereas the H4 activity has declined to less than 40% of its initial rate. The initial velocity is nearly identical for all four curves for over 2 sec. Total time of reaction is 25 sec. The horizontal lines are artifacts. The difference in degree of inhibition of the two human enzymes in the presence of 0.02 M pyruvate is seen in Fig. 2 . The initial activities are within 15% of each other and are close to the activities at low concentrations of pyruvate (Table 4) . However, in the steady state the M4 isozyme shows 62% of its initial activity, whereas the H4 enzyme displays only 31% of its initial activity (Table 4) .
We exploited this difference in steady-state velocities in order to determine, in a single assay, both the isoenzyme composition and the total activity of a sample. The Total time of the reactions is 25 sec.
Four solutions of different composition were made from M4
and H4 LDH solutions whose activities were previously established. Assays in the stopped-flow spectrophotometer gave initial velocities and subunit compositions close to the expected values (Table 5 and Fig. 3 ).
In vivo, LDH exists in all five possible tet~rameric combinations of the H and M subunits; H4, HUM1, H2M2, H1MS, and M4. We isolated the intermediate "hybrid" isoenzymes from human heart tissue. Assay of the hybrid fractions by the stopped-flow technique showed heart/muscle subunit compositions of 73/27, 51/49, and 18/82, respectively, for the isolated H3M1, H2M2, and HM3 enzymes (Table 6 ). Fig. 4 shows the~reaction rates of equal activities of the three hy- Tissue extracts Human tissues have characteristic LDH isoenzyme patterns. During tissue breakdown, the enzyme is released into the serum, causing an increased concentration of the enzyme in serum, in a pattern comparable to--that seen in the tissue. Knowledge of the isoenzyme patterns in normal tissue can thus be used to help determine the source of the increased concentrations of LDH in serum. We measured the relative H and M activities in crude extracts of human kidney, liver, lung, skeletal muscle, and spleen by the stopped-flow method. Subunit composition ranged from 96% M-type protein in the liver to 18% M-type in thed'kidney; these values are compatible with the 88% M and 21% M-type, respectively, that have been determined by electrophoretic methods (15) . Skeletal muscle, lung, and spleen were intermediate in composition, showing 69, 58, and 58% M subunits, respectively, comparable to the 59, 53, and 46% M subunits estimated from electrophoresis patterns (15) . The LDH isoenzyme pattern in skeletal muscles varies with the type of muscle, the more aerobic muscles having a higher H/M ratio than the predominantly anaerobic muscles.
A sample of blood bank serum yielded an average value of 71% H-type subunits by the stopped-flow method; this value is within the normal range observed with electrophoretic methods (17) .
Changes in serum LDH activity during hepatitis
We observed changes in LDH activity and subunit composition in the serum of a patient who was hospitalized for hepatitis. During the acute phase of the disease, 2 days after admission to the hospital, the patient's serum LDH activity was 1512 arbitrary units (Table 7 ). Two weeks later the level had dropped to 931, and 3 weeks later it had decreased to 826. The normal blood bank serum activity of LDH by our method gave an average value of 686 units. The proportion of M-type LDH in the serum dropped from 70 to 53% during the 3-week period, and was thus still somewhat elevated. In Fig. 5 , the reaction rates of sera from 2 days after admission and from 2 weeks later are compared with that of normal serum. All three sera were diluted to the same total LDH activity so that the changing degree of inhibition could be observed. Proc. Nat. Acad. Sci. USA 69 (1972) DISCUSSION The findings reported here indicate that kinetic differences exist between human H4 and M4 LDH that closely parallel those found in many other species. The differential inhibition of the heart and muscle enzymes also occurs with LDH from fish, birds, and mammals, and its mechanism has been extensively studied in the chicken (13) .
An abortive ternary complex has been proposed as the inhibitory moiety producing the marked inhibition of the H enzyme at high pyruvate concentrations (3, 13, 18, 19) . This complex consists of DPN+, pyruvate, and enzyme. Our data indicate that the human enzymes, especially the H-type, will be inhibited by a high concentration of pyruvate, as well as by previous incubation with DPN+ in the presence of pyruvate. As with the chicken enzyme, this inhibition can be enhanced by substitution of (AcPy)DPN+ for the natural coenzyme (3, 13) .
Lack of inhibition for the first several seconds in the absence of DPN+, even in the presence of high concentrations of pyruvate, demonstrates the requirement of DPN+ for complex formation. As the reaction proceeds and the oxidized coenzyme is produced, inhibition is initiated.
The difference-in the degree of inhibition between the two types of LDH permits the rapid determination of the ratio of the H and M types, as well as the total enzymatic activity of a sample. The activity in the initial uninhibited part of the reaction correlates with the total activity as determined at law pyruvate concentration. The ratios of initial activity to steady-state velocity for pure M4 and H4 enzymes can then be used to calculate the percentages of each subunit from the ratio given by the sample.
Experiments with the hybrid enzymes and with mixtures of known composition of the H4 and M4 LDH demonstrate the accuracy that is attained by this method (Tables 5 and 6 ). We believe that this method determines LDH subunit composition more accurately than electrophoretic procedures. However, as with electrophoretic procedures, the accuracy of the determination of the ratio of H to M subunits is greatest when the two are present in equal concentrations and diminishes as one type of subunit becomes predominant.
The applicability of this method of subunit determination to human sera should make possible its use as a diagnostic tool in clinical medicine. Our data from a patient with hepatitis demonstrates its possible application as a monitoring device in patients with liver disease. LDH isoenzyme concentrations are widely used as a diagnostic indicator in myocardial infarction. The speed of stopped-flow isoenzyme assays should make the method valuable as an early indicator of myocardial damage and should supply a mechanism for monitoring further infarction.
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ADDENDUM
We determined the initial velocity (Vi) by measuring the difference between the absorbances at 340 nm that were obtained at 0.5 and 1.5 sec after the reaction was initiated. In order to measure the degree of inhibition, we again recorded the change in absorbance between 12.5 and 13.5 sec (Vs). Standards of pure human M4 and pure H4 isozymes were assayed daily to determine the constants used in the calculations.
The velocity of the reaction at 13 sec is a linear function of its initial velocity. That is, kiVI(s) = Vs(I) and k2VI(u) = V8(M), where VI is the initial velocity measured at 1 sec, and Vs represents the steady-state velocity measured at 13 sec. By the measurement of VI and Vs for the standards, k1 and k2 may be established.
Since any sample of LDH consists of H and M subunits that are catalytically independent of each other, its rate curve can be regarded as the sum of the curves for its H and M components. The initial activity of the sample, as well as its steady-state activity (VI(s) and Vs(s)), are measured from the total curve.
Then, VI(s) = VI(M) + VI(a) [1] and Vs ( [2]
By solving (1) and [2] for VI(H), we obtain:
VI(H) = (k2VI(B) -Vs(8))/(k2 -ki) % H subunits in the initial sample = VI(s)/VI(s) and % M subunits = 100 -% H subunits.
